
Siam Bioscience reports its record profit after vaccine deal with AstraZeneca
Thai medical firm Siam Bioscience, owned by the King Maha Vajiralongkorn, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc’s COVID-19 vaccine. According …
Siam Bioscience reports its record profit after vaccine deal with AstraZeneca Read More